Jeff Yass’s Rennova Health, Inc. RNVA Stock Holding History

Jeff Yass’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-124	Closed	-$5K	–	10700
2016 Q4	$5K	Buy	+124	New	+$7.04K	﹤0.01%	9489
2015 Q3	–	Sell	-18	Closed	-$56K	–	10640
2015 Q2	$56K	Buy	+18	New	+$67.6K	﹤0.01%	9853

Other funds holding RNVA

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jeff Yass's RNVA Position: Q1 2017 in Review

Jeff Yass sold out of Rennova Health, Inc. (RNVA) in Q1 2017, closing a stake of 124 shares — an estimated $5K sold.

Jeff Yass first reported a position in RNVA in Q2 2015 and held it in 2 quarters. The position peaked at $56K in Q2 2015. 9 funds tracked by Wall St. Rank hold RNVA as of Q1 2017.

Jeff Yass reported no remaining Rennova Health, Inc. position as of Q1 2017 after selling out during the quarter.
Jeff Yass sold 124 Rennova Health, Inc. shares in Q1 2017, an estimated $5K.
Jeff Yass first reported a position in Rennova Health, Inc. in Q2 2015 and held it in 2 quarters.
Jeff Yass's Rennova Health, Inc. position peaked at $56K in Q2 2015.
9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.